| 13.4 0.39 (3%) | 10-24 14:53 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.46  |
1-year : | 17.47 |
| Resists | First : | 14.1 |
Second : | 14.96 |
| Pivot price | 13.69 |
|||
| Supports | First : | 12.71 | Second : | 10.57 |
| MAs | MA(5) : | 13.77 |
MA(20) : | 13.59 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 36.5 |
D(3) : | 50.4 |
| RSI | RSI(14): 48.1 |
|||
| 52-week | High : | 16.2 | Low : | 11.81 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CARL ] has closed above bottom band by 38.0%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 13.91 - 14.02 | 14.02 - 14.09 |
| Low: | 12.77 - 12.89 | 12.89 - 12.97 |
| Close: | 12.85 - 13.04 | 13.04 - 13.16 |
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 27 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 42 (%) |
| Held by Institutions | 1.2 (%) |
| Shares Short | 745 (K) |
| Shares Short P.Month | 508 (K) |
| EPS | -1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -18.05 |
| Profit Margin | -65.5 % |
| Operating Margin | -53.9 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 98.6 % |
| Gross Profit (p.s.) | 1.06 |
| Sales Per Share | 1.43 |
| EBITDA (p.s.) | -0.93 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -27 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -13.64 |
| PEG Ratio | 0 |
| Price to Book value | -0.75 |
| Price to Sales | 9.37 |
| Price to Cash Flow | -13.3 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|